Abstract:
A method of epimerizing an ( S )-1-benzylisoquinoline alkaloid to an ( R )-1 -benzylisoquinoline alkaloid is provided. The method comprises contacting the ( S )-1 -benzylisoquinoline alkaloid with at least one enzyme. Contacting the ( S )-1 -benzylisoquinoline alkaloid with the at least one enzyme converts the (S)-1 - benzylisoquinoline alkaloid to an ( R )-1 -benzylisoquinoline alkaloid.
Abstract:
Engineered non-plant cells that produce a benzylisoquinoline alkaloid product that is a derivative of canadine along a metabolic pathway that converts canadine, or an analog of canadine, to a noscapinoid product are provided. Methods of culturing engineered non-plant cells that produce a noscapinoid product and pharmaceutical compositions are also provided.